Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
Philippen L, Schub N, Günther A, Cario G, Schrappe M, Repp R, Gramatzki M. Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease. Bone Marrow Transplant 2023; 59:153-155.
Nov 6, 2023
Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
Nov 6, 2023
Bone Marrow Transplant 2023; 59:153-155
Philippen Lennart, Schub Natalie, Günther Andreas, Cario Gunnar, Schrappe Martin, Repp Roland, Gramatzki Martin
more
